about
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System disc...
Read More
1.35
0.13
(10.66%)
2.0M
XNAS Volume
XNAS 08 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Biomea Fusion Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..